The bill titled the “Stop STALLING Act” aims to prevent companies from filing sham citizen petitions that delay the approval of generic drugs or biosimilars, thereby fostering competition in the drug market. It allows the Federal Trade Commission (FTC) to take action against individuals or...
Simple Explanation
The "Stop STALLING Act" tries to stop people from making fake complaints that slow down the approval of cheaper medicines. It wants to make sure that real concerns about medicine safety can still be heard, while those who trick the system to stop competition can be fined by the government.